Perioperative outcomes from a randomized controlled trial comparing MRI-guided transurethral ultrasound ablation (TULSA) to robot-assisted radical prostatectomy (RARP).
Ruben Olivares(Cleveland Clinic), Laurence Klotz(Sunnybrook Health Science Centre), Kiarash Michel(Comprehensive Cardiovascular), Chin Jl(London Health Sciences Centre), Arvin K. George(Johns Hopkins University), M. Anttinen(Turku University Hospital), Y. Lotan(Southwestern Medical Center), Brant A. Inman(Duke Medical Center), Geoffrey A. Sonn(Stanford Medicine), Naveen Kella(Urology San Antonio), Xiaosong Meng(Guizhou University), Wayne Brisbane(University of California, Los Angeles), Preston C. Sprenkle(Yale Cancer Center), Michael O. Koch(Indiana University School of Medicine), Ram Pathak(Jacksonville College), R.I. Carey(Sarasota Memorial Hospital), Christian Pavlovich(Johns Hopkins University), Clint D. Bahler(Indiana University – Purdue University Indianapolis), Lance A. Mynderse(Mayo Clinic), Rahul Mehan(Middle East Studies Association of North America)
Cited by 0
Related Papers
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
An overview of kidney stone imaging techniques
|Nature Reviews Urology|2016|389
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016
|Journal of the National Comprehensive Cancer Network|2016|345
Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study
|Journal of Clinical Oncology|2017|175
Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling
|European Urology|2022|169